Please use this identifier to cite or link to this item: https://doi.org/10.1186/s12913-021-06056-5
DC FieldValue
dc.titleA multi-stakeholder approach to the co-production of the research agenda for medicines optimisation
dc.contributor.authorFellenor, John
dc.contributor.authorBritten, Nicky
dc.contributor.authorCourtenay, Molly
dc.contributor.authorPayne, Rupert A
dc.contributor.authorValderas, Jose
dc.contributor.authorDenholm, Rachel
dc.contributor.authorDuncan, Polly
dc.contributor.authorMcCahon, Deborah
dc.contributor.authorTatnell, Lynn
dc.contributor.authorFitzgerald, Richard
dc.contributor.authorWarmoth, Krystal
dc.contributor.authorGillespie, David
dc.contributor.authorTurner, Katrina
dc.contributor.authorWatson, Margaret
dc.date.accessioned2023-01-25T04:09:27Z
dc.date.available2023-01-25T04:09:27Z
dc.date.issued2021-01-13
dc.identifier.citationFellenor, John, Britten, Nicky, Courtenay, Molly, Payne, Rupert A, Valderas, Jose, Denholm, Rachel, Duncan, Polly, McCahon, Deborah, Tatnell, Lynn, Fitzgerald, Richard, Warmoth, Krystal, Gillespie, David, Turner, Katrina, Watson, Margaret (2021-01-13). A multi-stakeholder approach to the co-production of the research agenda for medicines optimisation. BMC HEALTH SERVICES RESEARCH 21 (1). ScholarBank@NUS Repository. https://doi.org/10.1186/s12913-021-06056-5
dc.identifier.issn1472-6963
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/236316
dc.description.abstractBackground: Up to 50% of medicines are not used as intended, resulting in poor health and economic outcomes. Medicines optimisation is ‘a person-centred approach to safe and effective medicines use, to ensure people obtain the best possible outcomes from their medicines’. The purpose of this exercise was to co-produce a prioritised research agenda for medicines optimisation using a multi-stakeholder (patient, researcher, public and health professionals) approach. Methods: A three-stage, multiple method process was used including: generation of preliminary research questions (Stage 1) using a modified Nominal Group Technique; electronic consultation and ranking with a wider multi-stakeholder group (Stage 2); a face-to-face, one-day consensus meeting involving representatives from all stakeholder groups (Stage 3). Results: In total, 92 research questions were identified during Stages 1 and 2 and ranked in order of priority during stage 3. Questions were categorised into four areas: ‘Patient Concerns’ [e.g. is there a shared decision (with patients) about using each medicine?], ‘Polypharmacy’ [e.g. how to design health services to cope with the challenge of multiple medicines use?], ‘Non-Medical Prescribing’ [e.g. how can the contribution of non-medical prescribers be optimised in primary care?], and ‘Deprescribing’ [e.g. what support is needed by prescribers to deprescribe?]. A significant number of the 92 questions were generated by Patient and Public Involvement representatives, which demonstrates the importance of including this stakeholder group when identifying research priorities. Conclusions: A wide range of research questions was generated reflecting concerns which affect patients, practitioners, the health service, as well the ethical and philosophical aspects of the prescribing and deprescribing of medicines. These questions should be used to set future research agendas and funding commissions.
dc.language.isoen
dc.publisherBMC
dc.sourceElements
dc.subjectScience & Technology
dc.subjectLife Sciences & Biomedicine
dc.subjectHealth Care Sciences & Services
dc.subjectMedicines optimisation
dc.subjectPolypharmacy
dc.subjectDeprescribing
dc.subjectPatient concerns
dc.subjectNon-medical prescribing
dc.subjectNominal group technique
dc.typeArticle
dc.date.updated2023-01-20T10:31:37Z
dc.contributor.departmentDEPT OF MEDICINE
dc.description.doi10.1186/s12913-021-06056-5
dc.description.sourcetitleBMC HEALTH SERVICES RESEARCH
dc.description.volume21
dc.description.issue1
dc.published.statePublished
Appears in Collections:Staff Publications
Elements

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
A multi-stakeholder approach to the co-production of the research agenda for medicines optimisation.pdfPublished version973.9 kBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.